Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Survey of clopidogrel use in a teaching hospital|
|Citation:||Journal of Pharmacy Practice and Research, 2006; 36(1):40-43|
|Publisher:||Society of Hospital Pharmacists of Australia|
|Organisation:||Medicine Learning and Teaching Unit|
|Paul Armenores, Stephanie L Wiltshire,Anne L Tonkin,Sepehr Shakib|
|Abstract:||Aim: To develop guidelines for clopidogrel prescribing and survey its use to ascertain the need for changes in prescribing patterns. Method: Guidelines were developed after a literature review. Prescribing patterns were assessed by a cross sectional survey which investigated the therapy of inpatients identified taking clopidogrel at a teaching hospital over a 2-month period. Measures of concordance were indications for clopidogrel, contraindications to NSAIDs, timing and range of clopidogrel dosage and associated use of aspirin. Results: Data were collected from 69 patients. 29 (42%) were taking clopidogrel for secondary prevention of ischaemic heart disease - 14 for appropriate indications. 23 (33%) were given clopidogrel before and/or following percutaneous coronary intervention - 11 had an appropriate combined aspirin and clopidogrel loading dose, and 20 had appropriate combined long term therapy. 15 (22%) received clopidogrel for secondary prevention of cerebrovascular disease and 7/15 had appropriate indications. 2 (2.9%) patients with peripheral vascular disease and 1 (1.4%) with chronic atrial fibrillation were treated directly with clopidogrel. 3 (4.3%) patients had unknown indications. Conclusions: A large proportion of clopidogrel prescribing did not have a good evidence base. For safety and economic reasons, prescribers need to be made aware of current evidence and recommendations.|
|Appears in Collections:||Pharmacology publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.